Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbetocin versus rectal misoprostol for management of the third stage of labor in women at low risk of postpartum hemorrhage
PACTR201604001604186Not yet recruiting
- Sponsor
- Cambridge University Hospitals
- Start
- May 2016
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Trial of carbetocin and misoprostol in postpartum hemorrhage (PPH) (2 arms), sponsored by Cambridge University Hospitals. Primary endpoint: Prevention of primary postpartum hemorrhage. Planned start May 2016; status: not yet recruiting.
02
Drugs
carbetocinmisoprostol
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on PACTR201604001604186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201604001604186.